News
Osteopore specialises in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing.
Osteopore is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopaedic, and maxillofacial surgery use.
Osteopore products are made of a US FDA approved polymer called polycaprolactone (PCL). PCL is bioresorbable, malleable, slow-degrading and possesses mechanical strength similar to trabecular bone.
KEY PEOPLE
RELATED STOCKHEAD STORIES
News
Market Highlights: Aussie becomes first to sue ChatGPT for defamation, and 5 ASX small caps to watch today
Health & Biotech
ASX Health Stocks: Patrys crashes after Phase 1 delayed till 2024, Nova Eye surges 20pc on FDA OK
Health & Biotech
Osteopore acquires multiple medical distribution businesses, closing in on cash flow positive
News
Market Highlights: ASX to surge on Big Tech rally; and 5 small caps to watch on Monday
News
Closing Bell: ASX finishes down 0.21% as the market limps towards Xmas
News
LAST ORDERS: A sleepy look back Monday’s news you might have missed
Health & Biotech
ASX Health Stocks: Imagion jumps 20pc after delivering positive Phase 1 results
Health & Biotech
On the nose – Osteopore taps into lucrative rhinoplasty market with bioresorbable polymer scaffold
News
Closing Bell: Small cap index edges higher, WA1 Resources now up 550% in 4 sessions
Health & Biotech
Osteopore hits record revenue in Q3 and achieves 4 consecutive quarters of revenue growth, ticks boxes for future growth
Experts
Innovation never sleeps: Franklin Templeton says watch these 5 big tech shifts this quarter
Health & Biotech
Osteopore secures funding to chase world-first 3D printable implant for accelerated bone regeneration
Health & Biotech
Osteopore’s products will be included in Australia’s Prostheses List in November
Health & Biotech
Check Up: As the pandemic winds down, what’s happening with Covid focused biotechs?
Stockhead TV
Investor Presentation: Osteopore (ASX:OSX)
Health & Biotech
Osteopore is a step closer to the huge Chinese market after signing a distribution deal
Health & Biotech